Cargando…

Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease

BACKGROUND: In the final phase of clot formation, fibrinogen constitutes frame, whereas factor XIII (FXIII) active form is responsible for the covalent cross-linking of fibrin fibres and plasmin inhibitor (PI), thus contributing to clot stability. It could be expected that any change of coagulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Bronić, Ana, Ferenčak, Goran, Bernat, Robert, Leniček-Krleža, Jasna, Dumić, Jerka, Dabelić, Sanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982289/
https://www.ncbi.nlm.nih.gov/pubmed/33776563
http://dx.doi.org/10.5937/jomb0-26839
_version_ 1783667690023419904
author Bronić, Ana
Ferenčak, Goran
Bernat, Robert
Leniček-Krleža, Jasna
Dumić, Jerka
Dabelić, Sanja
author_facet Bronić, Ana
Ferenčak, Goran
Bernat, Robert
Leniček-Krleža, Jasna
Dumić, Jerka
Dabelić, Sanja
author_sort Bronić, Ana
collection PubMed
description BACKGROUND: In the final phase of clot formation, fibrinogen constitutes frame, whereas factor XIII (FXIII) active form is responsible for the covalent cross-linking of fibrin fibres and plasmin inhibitor (PI), thus contributing to clot stability. It could be expected that any change of coagulation factors' structure affects the clot formation and modulates the atherothrombotic risk. The aim was to determine the frequency of four single nucleotide polymorphisms: (i) A > G in codon 312 of the fibrinogen α-chain gene (rs6050, Thr312AlaFGA), (ii) C > T at position 10034 of the 3 - untranslated region in the fibrinogen γ-chain gene (rs2066865, 10034C > T FGG), (iii) C > T in codon 564 of the FXIII-A subunit gene (rs5982, Pro564LeuFXIII-A), and (iv) C > T in codon 6 of the plasmin inhibitor gene (rs2070863, Arg6TrpPI) in Croatian patients and their association with coronary artery disease (CAD). METHODS: We performed the unrelated case-control association study on the consecutive sample of patients 18 years old, who had undergone coronary angiography for investigation of chest pain and suspected CAD. The cases were patients with confirmed CAD (N=201), and the controls were the subjects with no CAD (N=119). Samples were genotyped using PCR-RFLP analysis. RESULTS: Observed frequencies of the rare alleles of Thr312Ala FGA, 10034C > T FGG, Leu564Pro FXIII-A and Arg6Trp PI polymorphisms were 21%, 17%, 14%, 20%, respectively. Patients with 10034C > T FGG CC genotype had 3.5 times (95% CI 1.02-12.03) higher adjusted odds for CAD than patients with 10034C > T FGG TT genotype. Patients with Arg6Trp PI CC genotype had 3.86 times (95% CI 1.23-12.12) higher odds for CAD than patients with Arg6Trp PI TT genotype. It seems that those genotype-related higher odds are also male-gender related. No difference was observed regarding any other investigated polymorphism. CONCLUSIONS: Our finding suggests that 10034C > T FGG and Arg6Trp PI are associated with CAD.
format Online
Article
Text
id pubmed-7982289
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format MEDLINE/PubMed
spelling pubmed-79822892021-03-26 Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease Bronić, Ana Ferenčak, Goran Bernat, Robert Leniček-Krleža, Jasna Dumić, Jerka Dabelić, Sanja J Med Biochem Original Paper BACKGROUND: In the final phase of clot formation, fibrinogen constitutes frame, whereas factor XIII (FXIII) active form is responsible for the covalent cross-linking of fibrin fibres and plasmin inhibitor (PI), thus contributing to clot stability. It could be expected that any change of coagulation factors' structure affects the clot formation and modulates the atherothrombotic risk. The aim was to determine the frequency of four single nucleotide polymorphisms: (i) A > G in codon 312 of the fibrinogen α-chain gene (rs6050, Thr312AlaFGA), (ii) C > T at position 10034 of the 3 - untranslated region in the fibrinogen γ-chain gene (rs2066865, 10034C > T FGG), (iii) C > T in codon 564 of the FXIII-A subunit gene (rs5982, Pro564LeuFXIII-A), and (iv) C > T in codon 6 of the plasmin inhibitor gene (rs2070863, Arg6TrpPI) in Croatian patients and their association with coronary artery disease (CAD). METHODS: We performed the unrelated case-control association study on the consecutive sample of patients 18 years old, who had undergone coronary angiography for investigation of chest pain and suspected CAD. The cases were patients with confirmed CAD (N=201), and the controls were the subjects with no CAD (N=119). Samples were genotyped using PCR-RFLP analysis. RESULTS: Observed frequencies of the rare alleles of Thr312Ala FGA, 10034C > T FGG, Leu564Pro FXIII-A and Arg6Trp PI polymorphisms were 21%, 17%, 14%, 20%, respectively. Patients with 10034C > T FGG CC genotype had 3.5 times (95% CI 1.02-12.03) higher adjusted odds for CAD than patients with 10034C > T FGG TT genotype. Patients with Arg6Trp PI CC genotype had 3.86 times (95% CI 1.23-12.12) higher odds for CAD than patients with Arg6Trp PI TT genotype. It seems that those genotype-related higher odds are also male-gender related. No difference was observed regarding any other investigated polymorphism. CONCLUSIONS: Our finding suggests that 10034C > T FGG and Arg6Trp PI are associated with CAD. Society of Medical Biochemists of Serbia, Belgrade 2021-03-12 2021-03-12 /pmc/articles/PMC7982289/ /pubmed/33776563 http://dx.doi.org/10.5937/jomb0-26839 Text en 2021 Ana Bronić, Goran Ferenčak, Robert Bernat, Jasna Leniček-Krleža, Jerka Dumić, Sanja Dabelić, published by CEON/CEES http://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License.
spellingShingle Original Paper
Bronić, Ana
Ferenčak, Goran
Bernat, Robert
Leniček-Krleža, Jasna
Dumić, Jerka
Dabelić, Sanja
Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
title Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
title_full Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
title_fullStr Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
title_full_unstemmed Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
title_short Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
title_sort association of fibrinogen and plasmin inhibitor, but not coagulation factor xiii gene polymorphisms with coronary artery disease
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982289/
https://www.ncbi.nlm.nih.gov/pubmed/33776563
http://dx.doi.org/10.5937/jomb0-26839
work_keys_str_mv AT bronicana associationoffibrinogenandplasmininhibitorbutnotcoagulationfactorxiiigenepolymorphismswithcoronaryarterydisease
AT ferencakgoran associationoffibrinogenandplasmininhibitorbutnotcoagulationfactorxiiigenepolymorphismswithcoronaryarterydisease
AT bernatrobert associationoffibrinogenandplasmininhibitorbutnotcoagulationfactorxiiigenepolymorphismswithcoronaryarterydisease
AT lenicekkrlezajasna associationoffibrinogenandplasmininhibitorbutnotcoagulationfactorxiiigenepolymorphismswithcoronaryarterydisease
AT dumicjerka associationoffibrinogenandplasmininhibitorbutnotcoagulationfactorxiiigenepolymorphismswithcoronaryarterydisease
AT dabelicsanja associationoffibrinogenandplasmininhibitorbutnotcoagulationfactorxiiigenepolymorphismswithcoronaryarterydisease